—The screening protocol for intracranial aneurysm in patients with autosomal dominant polycystic kidney disease should be based on the presence and size of the aneurysm, family history, and age ...
KALAMAZOO, MI -- Scientists at Western Michigan University Homer Stryker School of Medicine (WMed) have made a ...
Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications ...
A team of researchers at Western Michigan University's Homer Stryker M.D. School of Medicine has made a monumental ...
A research team at Western Michigan University Homer Stryker M.D. School of Medicine has made a significant discovery.
The case was a tricky one, a surgery was inevitable. The patient had lost a lot of blood. He was also in severe pain. Then, ...
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.
In an indication that has proved difficult for biopharma to conquer, Regulus Therapeutics Inc. disclosed further positive data from its ongoing phase Ib study testing RGLS-8429 in autosomal dominant ...
(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program.